Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Foreman

Showing results (291-300 of 326) with videos related to

Pageof 33
Sort By:
Oncotarget|July 25, 2016
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastomaEric W Prince, Ilango Balakrishnan, Monil Shah, et al.
The Journal of Biological Chemistry|June 6, 2003
Transcriptional regulation of biomass-degrading enzymes in the filamentous fungus Trichoderma reeseiPamela K Foreman, Doug Brown, Lydia Dankmeyer, et al.
The Lancet. Oncology|July 28, 2022
Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupHolly B Lindsay, Maura Massimino, Shivaram Avula, et al.
Pediatric Blood & Cancer|May 26, 2017
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium studyMargaret E Macy, Mark W Kieran, Susan N Chi, et al.
Neuro-Oncology|May 17, 2017
NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymomaAndrea M Griesinger, Davis A Witt, Sydney T Grob, et al.
Neuro-Oncology|February 4, 2025
Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growthGraziella Ribeiro de Sousa, Annaliese J Calzadilla, Enrique Grimaldo, et al.
Brain Pathology (Zurich, Switzerland)|June 30, 2025
Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterationsShadi Zahedi, Kent Riemondy, Tian Liu, et al.
JCI Insight|April 8, 2026
JAK inhibition may prevent drug hypersensitivity reactionsXiangmei Hua, Pranali N Shah, Gustavo A Velasquez, et al.
Neuro-Oncology|July 6, 2019
Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymomaAngela M Pierce, Davis A Witt, Andrew M Donson, et al.
Neuro-Oncology|June 2, 2021
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastomaKent A Riemondy, Sujatha Venkataraman, Nicholas Willard, et al.
Pageof 33

Showing results (291-300 of 326) with videos related to

Sort By:
Pageof 33
Oncotarget|July 25, 2016
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastomaEric W Prince, Ilango Balakrishnan, Monil Shah, et al.
The Journal of Biological Chemistry|June 6, 2003
Transcriptional regulation of biomass-degrading enzymes in the filamentous fungus Trichoderma reeseiPamela K Foreman, Doug Brown, Lydia Dankmeyer, et al.
The Lancet. Oncology|July 28, 2022
Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupHolly B Lindsay, Maura Massimino, Shivaram Avula, et al.
Pediatric Blood & Cancer|May 26, 2017
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium studyMargaret E Macy, Mark W Kieran, Susan N Chi, et al.
Neuro-Oncology|May 17, 2017
NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymomaAndrea M Griesinger, Davis A Witt, Sydney T Grob, et al.
Neuro-Oncology|February 4, 2025
Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growthGraziella Ribeiro de Sousa, Annaliese J Calzadilla, Enrique Grimaldo, et al.
Brain Pathology (Zurich, Switzerland)|June 30, 2025
Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterationsShadi Zahedi, Kent Riemondy, Tian Liu, et al.
JCI Insight|April 8, 2026
JAK inhibition may prevent drug hypersensitivity reactionsXiangmei Hua, Pranali N Shah, Gustavo A Velasquez, et al.
Neuro-Oncology|July 6, 2019
Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymomaAngela M Pierce, Davis A Witt, Andrew M Donson, et al.
Neuro-Oncology|June 2, 2021
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastomaKent A Riemondy, Sujatha Venkataraman, Nicholas Willard, et al.
Pageof 33